Safety of sacubitril/valsartan among older adults. Where real world data meet clinical trials results

被引：1
|
作者：
Garcia-Moll, Xavier [1 ]
Lopez, Laura [1 ]
机构：
[1] Hosp Holy Cross & St Paul, Cardiol Dept, Barcelona, Spain
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2024年 / 400卷
关键词：
HEART-FAILURE;
D O I：
10.1016/j.ijcard.2023.131706
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Sex Differences in Risk for Iatrogenic Thyrotoxicosis Among Older Adults: An Analysis from Real-World Clinical Data
    Adams, Roy
    Mammen, Jennifer Sophie
    THYROID, 2025,
  • [12] The real-world safety of ticagrelor among older adults (above 75 years): a pharmacovigilance study from the FDA data
    Lerman, T.
    Yacoby, I.
    Fishman, B.
    Goldman, A.
    Talmor-Barkan, Y.
    Itelman, E.
    Orvin, K.
    Eisen, A.
    Kornowski, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [13] The real-world safety of ticagrelor among older adults (above 75 years): a pharmacovigilance study from the FDA data
    Lerman, T.
    Yacoby, I
    Fishman, B.
    Goldman, A.
    Talmor-Barkan, Y.
    Itelman, E.
    Orvin, K.
    Eisen, A.
    Kornowski, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [14] The Gap Between Clinical Trials and the Real World Extrapolating Treatment Effects From Younger to Older Adults
    Tinetti, Mary E.
    JAMA INTERNAL MEDICINE, 2014, 174 (03) : 397 - 398
  • [15] The role of sacubitril/valsartan in the treatment of chronic heart failure with reduced ejection fraction in hypertensive patients with comorbidities: From clinical trials to real-world settings
    Mazza, Alberto
    Townsend, Danyelle M.
    Torin, Gioia
    Schiavon, Laura
    Camerotto, Alessandro
    Rigatelli, Gianluca
    Cuppini, Stefano
    Minuz, Pietro
    Rubello, Domenico
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
  • [16] Sacubitril/valsartan use patterns among older adults with heart failure in clinical practice: a population-based cohort study of >25 000 Medicare beneficiaries
    Bhatt, Ankeet S.
    Vaduganathan, Muthiah
    Solomon, Scott D.
    Schneeweiss, Sebastian
    Lauffenburger, Julie C.
    Desai, Rishi J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (09) : 1506 - 1515
  • [17] Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data
    D'Cruz, David
    Eriksson, Gina
    Green, Yulia
    Hammer, Anne
    Ji, Beulah
    Meizlik, Paige
    Roth, David A.
    LUPUS SCIENCE & MEDICINE, 2023, 10 (01):
  • [18] TOLERABILITY OF SACUBITRIL/VALSARTAN TREATMENT IN OLDER PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: PRELIMINARY DATA FROM THE REAL-WORLD AGING-HF REGISTRY
    Herbst, A.
    Orso, F.
    Camartini, V.
    Virciglio, S.
    D'Errico, G.
    Salucci, C.
    Verga, F.
    Fattirolli, F.
    Marchionni, N.
    Di Bari, M.
    Ungar, A.
    Baldasseroni, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 (SUPPL C)
  • [19] Real-world safety of neurohormonal antagonist initiation among older adults following a heart failure hospitalization
    Goyal, Parag
    Zullo, Andrew R.
    Gladders, Barbara
    Onyebeke, Chukwuma
    Kwak, Min Ji
    Allen, Larry A.
    Levitan, Emily B.
    Safford, Monika M.
    Gilstrap, Lauren
    ESC HEART FAILURE, 2023, 10 (03): : 1623 - 1634
  • [20] Efficacy and safety of sacubitril/valsartan in an outpatient setting: A single-center real-world retrospective study in HFrEF patients with focus on possible predictors of clinical outcome
    Froeb, Elisabeth J.
    Sindermann, Juergen R.
    Reinecke, Holger
    Tuleta, Izabela
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (05): : 475 - 487
12345